Skip to main content

Table 2 Effects of various variables on anthracycline-induced subclinical cardiotoxicity in DLBCL patients completed 3 cycles chemotherapy

From: Study on influencing factors of anthracycline-induced subclinical cardiotoxicity in DLBCL patients administered (R)-CHOP

Characteristics

OR (95%CI)

P-value

Age, per 1 year

1.000 (0.964, 1.036)

0.982

Male, yes versus no

0.833 (0.316, 2.201)

0.713

BMI, per 1 kg/m2

1.219 (1.033,1.438)

0.019

Smoking, yes versus no

3.304 (1.067, 10.226)

0.038

GLS, per -1%

1.200 (0.949, 1.517)

0.129

E, per 1 cm/s

1.030 (0.991, 1.070)

0.138

e’, per 1 cm/s

1.258 (0.980, 1.614)

0.071

LDL-C, per 1 mmol/L

2.016 (0.992,4.095)

0.053

HDL-C, per 1 mmol/L

0.371 (0.082, 1.683)

0.199

NT-proBNP, per 1 ng/L

0.993 (0.986,1.000)

0.066

TG, per 1 mmol/L

1.806 (0.942,3.462)

0.075

  1. Bold values indicate statistical significance
  2. BMI Body mass index, cTnT cardiac troponin T, Cr Creatinine, FS Fractional shortening, GLS Global longitudinal peak systolic strain, HDL-C High-density lipoprotein cholesterol, LDL-C Low-density lipoprotein cholesterol, NT-proBNP N terminal-pro brain natriuretic peptide, TG Total cholesterol
Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us